Related Experiment Video
Updated: Jun 14, 2026

05:54
Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
2.0K
Acupoint thread embedding compared to or in combination with biofeedback for treating anismus: A retrospective cohort
Hong Zhi Geng1, Xi Ye Mao2, Yue Ma2
1Department of Anorectal Surgery, Hepu People's Hospital, Guangxi Zhuang Autonomous Region, Beihai City, China.
Medicine
|December 2, 2025
Summary
The combination of Acupoint Thread Embedding (ATE) and Biofeedback Therapy (BFT) significantly improves anismus symptoms compared to monotherapy. A reduced Traditional Chinese Medicine Syndrome (TCMS) score predicts a better prognosis.
Area of Science:
- Gastroenterology
- Integrative Medicine
- Pelvic Floor Disorders
Background:
- Anismus, a defecation disorder, is typically treated with Biofeedback Therapy (BFT), but its efficacy is limited and recurrence is high.
- Acupoint Thread Embedding (ATE), a Traditional Chinese Medicine therapy, offers sustained stimulation and may complement BFT.
Purpose of the Study:
- To evaluate the short-term efficacy of ATE, BFT, and their combination for anismus.
- To explore the prognostic value of the Traditional Chinese Medicine Syndrome (TCMS) score in anismus treatment.
Main Methods:
- Retrospective cohort study of 150 anismus patients divided into ATE, BFT, and ATE+BFT groups.
- Primary outcomes: Cleveland Clinic Constipation (CCC) and TCMS scores at 3 months posttreatment.
- Secondary outcomes: Patient Assessment of Constipation Quality of Life (PAC-QOL) score, effectiveness, and safety at 3- and 6-month follow-ups.
Main Results:
- The ATE+BFT group showed significantly lower CCC, TCMS, and PAC-QOL scores at 3 months posttreatment compared to BFT alone.
- The combination therapy resulted in the highest total effectiveness rate (85.00%).
- A ≥5-point reduction in TCMS score at 3 months posttreatment independently predicted a favorable outcome.
Conclusions:
- Combined ATE and BFT therapy is superior to monotherapy for short-term anismus management.
- Reduced TCMS scores are a significant predictor of favorable prognosis in anismus patients.
- Further research is needed as all scores returned to baseline by 6-month follow-up.

